Angiogenesis Inhibitors Concept

subject area of

• A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma  Journal Articles
• A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer  Journal Articles
• A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC  Conferences
• Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma  Journal Articles
• Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer  Journal Articles
• Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis  Journal Articles
• Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study  Journal Articles
• Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study  Journal Articles
• Age-related macular degeneration: is polypoidal choroidal vasculopathy recognized and treated?  Journal Articles
• An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin  Journal Articles
• Angiogenesis and non-small cell lung cancer  Journal Articles
• Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure  Journal Articles
• Anti-Vascular Endothelial Growth Factor Therapy Regimens for Polypoidal Choroidal Vasculopathy: A Systematic Review  Journal Articles
• Anti-angiogenesis in Personalized Therapy of Lung Cancer  Journal Articles
• Anti-vascular endothelial growth factor therapy for age-related macular degeneration: a systematic review and network meta-analysis  Journal Articles
• Antiangiogenic Cancer Therapy with Microencapsulated Cells  Journal Articles
• Antiangiogenic Therapies in Non-Small-Cell Lung Cancer  Journal Articles
• Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema  Journal Articles
• Aqueous Humor Cytokines and Long-Term Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema  Journal Articles
• Bevacizumab in advanced lung cancer: in search of the right drug for the right patient.  Journal Articles
• Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration  Journal Articles
• Cardiotoxicity associated with sunitinib  Journal Articles
• Changes in plasma hormones and heart rate variability in patients receiving the cardiotoxic anti-cancer agent bevacizumab  Journal Articles
• Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial  Journal Articles
• Chloride Channel Inhibition Does Block the Protection of Ischemic Preconditioning in Myocardium  Journal Articles
• Combined Immunotherapy and Antiangiogenic Therapy of Cancer with Microencapsulated Cells  Journal Articles
• Combined Treatment of a Murine Breast Cancer Model with Type 5 Adenovirus Vectors Expressing Murine Angiostatin and IL-12: A Role for Combined Anti-Angiogenesis and Immunotherapy  Journal Articles
• Combined therapy with thrombospondin‐1 type I repeats (3TSR) and chemotherapy induces regression and significandy improves survival in a preclinical model of advanced stage epithelial ovarian cancer  Journal Articles
• Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer  Journal Articles
• Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER  Journal Articles
• Complications of intravitreal injections: 2022  Journal Articles
• Displacement Affinity Release of Antibodies from Injectable Hydrogels  Journal Articles
• Does the Addition of Biologic Agents to Chemotherapy in Patients with Unresectable Colorectal Cancer Metastases Result in a Higher Proportion of Patients Undergoing Resection? A Systematic Review and Meta-analysis  Journal Articles
• Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer  Journal Articles
• Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer  Journal Articles
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme  Journal Articles
• Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA Study  Journal Articles
• Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Meta-Analysis.  Journal Articles
• Efficacy and safety of anti-vascular endothelial growth agents for the treatment of polypoidal choroidal vasculopathy: A systematic review and meta-analysis  Journal Articles
• Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis  Journal Articles
• Five-Year Clinical Outcomes of Intravitreal Bevacizumab Versus Laser Photocoagulation for ROP  Journal Articles
• Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response  Journal Articles
• Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab  Journal Articles
• Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property  Journal Articles
• IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION  Journal Articles
• INHIBITION OF WILMS TUMOR XENOGRAFT PROGRESSION BY HALOFUGINONE IS ACCOMPANIED BY ACTIVATION OF WT-1 GENE EXPRESSION  Conferences
• Imaging Biomarkers and Their Impact on Therapeutic Decision-Making in the Management of Neovascular Age-Related Macular Degeneration  Journal Articles
• Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre  Journal Articles
• Intedanib, a triple kinase inhibitor of VEGFR, FGFR and PDGFR for the treatment of cancer and idiopathic pulmonary fibrosis.  Journal Articles
• Intracellular Cl⁻fluxes play a novel role in Ca²⁺handling in airway smooth muscle  Journal Articles
• Keloids: what do we know and what do we do next?  Journal Articles
• MANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY  Journal Articles
• Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials  Conferences
• Malignant Ascites Fluid (MAF), Including Ovarian-Cancer-Associated MAF, Contains Angiostatin and Other Factor(s) Which Inhibit Angiogenesis  Journal Articles
• Metastatic renal cell cancer treatments: An indirect comparison meta-analysis  Journal Articles
• Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions  Journal Articles
• Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner  Journal Articles
• Novel targets and approaches in advanced prostate cancer  Journal Articles
• Observations on the Use of the Avian Chorioallantoic Membrane (CAM) Model in Investigations into Angiogenesis  Journal Articles
• Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus  Journal Articles
• Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy  Journal Articles
• Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study)  Journal Articles
• PIGMENT EPITHELIAL DETACHMENT THICKNESS AND VARIABILITY AFFECTS VISUAL OUTCOMES IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION  Journal Articles
• Polypoidal choroidal vasculopathy in Canada  Journal Articles
• Prevalence and clinical implications of subretinal fluid in retinal diseases: a real-world cohort study  Journal Articles
• Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis  Journal Articles
• Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma  Journal Articles
• Rapid Expansion of Intravitreal Drug Injection Procedures, 2000 to 2008  Journal Articles
• Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials  Journal Articles
• SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY  Journal Articles
• Same-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center  Journal Articles
• Seasonal and Environmental Variations in Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor Injection: A Six-year Review  Journal Articles
• Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF165  Journal Articles
• Stroke Rates after Introduction of Vascular Endothelial Growth Factor Inhibitors for Macular Degeneration: A Time Series Analysis  Journal Articles
• Targeting Angiogenesis With Integrative Cancer Therapies  Journal Articles
• The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure  Journal Articles
• The Association between Retinal Thickness Fluctuations and Visual Outcomes under Anti-Vascular Endothelial Growth Factor Therapy: A Systematic Review and Meta-Analysis  Journal Articles
• Thromboprophylaxis during chemotherapy: NO  Journal Articles
• Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next?  Journal Articles
• Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyes  Journal Articles
• Treat‐and‐extend regimens of anti‐vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta‐analysis  Journal Articles
• Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer  Journal Articles
• Waiting room educational media effect on preinjection anxiety for initial intravitreal injections  Journal Articles
• [Economic evaluation of bevacizumab versus ranibizumab in neovascular age-related macular degeneration].  Journal Articles